Trinity Biotech plc (NASDAQ:TRIB)
Bands
Volume
200 SMA
50 SMA
20 SMA
Videos
Alerts
Articles
Events
Old Forum Content for TRIB
Make a Forum Post Become a member to view recent forum posts. Already a member? Sign in here.
- mogo: $TRIB keeps bouncing off the 50 DMA in an uptrend. Doing it again now (day #3).
- cshanggu: $trib any thoughts? no volume
- cshanggu: @cshanggu $trib sold most of them, scary volume
- mogo: @cshanggu $TRIB looks like it's getting accumulated. Low volume makes that hard to do without moving the stock too much, like today. I've been in (2/3 position) since it broke above 4.80 and just added 1/3 today at 6.20 (it looks like a pennant BO today). Just be careful of earnings. One source says they're on March 10 but I can't find a confirmation.
- rck89: $TRIB - @Bridget, @DAN - I own this stock at slightly lower prices (~5.90). Would you add to positions at this level? Lack of volume is scary! Your thoughts, please. Thanks.
-
DAN: ...
$TRIB -- Alert on this yesterday. Really good price action after Friday’s exhaustion rally.
$NETE -- From Douglas. Forming the bottom part of the base.
$OKE -- pullback buy.
$CMI -- Forming base at 50-day MA. Earnings tomorrow.
Requested Vi ... - StockMarketMentor: A Price Alert has been triggered for $TRIB Trinity Biotech plc. Click here to view associated video clip: http://stockmarketmentor.com/stockanalysis.html?ticker=TRIB&clip=132589
- DAN: @StockMarketMentor $TRIB Nice move today on $TRIB.
- DeepDiver: Thanks dan for $TRIB.
-
DAN: ...
$TRIB -- Diagnostic test kits for autoimmune, infectious, etc (incl COVID) Alert $5.25
$FLDM -- Alert $6.85
$JYNT -- A big move that does not pull back. Up another 25%...but note that it drifted sideways long enough to say hello to the 50-day movi ... - cmac: Animal spirits moving $TRIB today....very tight vol sq, but need more volume to be convinced as to this move.
- cmac: Adding to $TRIB on potential breakout
- cmac: $TRIB I like today's opening action, which took out a lot of stops, but held support. I have a starter position and feel that most tax loss selling is behind this one. The VS could set up a nice move - up or down - but managing risk via alerts and stops.
- cmac: $TRIB alert set for $7.11 . Nice vol squeeze although this is pure spec.
- steve71: $ACAD $PTLA $TRIB $ZIOP Small cap, little or no revenue, and mostly outperforming Acadia to 45 on imminent NDA, 55 on approval, 75 on buyout Portola filled the Monday gap. Trinity quiet, low volume climb. Ziopharm CAR-T consolidating a high base.
- steve71: $TRIB Trinity Biotech is breaking out of consolidation. Recent upgrade and bond offering the only news. Barron's pick in 2014 and 2015. Trinity sells lab test kits, and beat earnings mainly on their syphilis tests. The promise is in Meritas, a new Troponin detector for early detection of heart attacks. Meritas is scheduled for FDA submission 8/2015. With approval, it will probably be used in every E.R. in the country. Speedy diagnosis = early and accurate intervention = preserved myocardium.
- steve71: $CERS $IPCI $ACAD $PTLA $TRIB and $REGN Several of the small cap biotechs, and Regeneron, are again outperforming. None of these are in the CAR-T space. Interesting because there's no common research theme. Maybe it implies that investors don't see growth in other industries, so they're willing to take some risk here. Biotechs and banks.
- steve71: $TRIB Opened Trinity Biotech @ 17.50 A Barron's pick in both 2014 and 2015. Recent $100M issuance of exchangeable senior notes slammed the stock price. Looks priced in now, with an intact double bottom. That's my stop. Trinity expects 2016 approval of Meritas, a specific troponin measure system, to diagnose heart attacks in the E.R. This is big, as docs could rapidly begin thrombolysis with early diagnosis.
- steve71: $TRIB Pretty chart, and ignoring the biotech phlebotomy. But thinly traded.
- steve71: $TRIB Trinity Biotech was a 2014 Barron's pick, and lost 20%. Now it's a 2015 pick, and is up 15% in January. Irish maker of clinical lab tests. Their newest product, Meritas, is not yet FDA approved. It's a more specific test for cardiac troponin, a substance released in the acute phase of a heart attack. The Meritas machine can be kept in the emergency room, allowing very rapid diagnosis and intervention for acute M.I. Up sharply today, but no public news. Caveat - only trades 100,000 shares/day.
-
Forexpro: ...
Sizing Up Small-Caps: Favorable mention of $TRIB, manufacturer of diabetes testing instruments. Quotes a manager who thinks that 37 is a reasonable target (last at 23). New products include a test (Meritas) for Troponin I, useful in diagnosing heart ...
| Stock Price | $1.84 |
| Change | -2.13% |
| Volume | 208 |
Trinity Biotech PLC develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market.
Request Video of TRIBAlready a member? Sign in here.
Past Month
Leading Peers
-
$63.62 7.71%
-
$47.22 0.34%
-
$127.23 -1.15%
Past Month
Lagging Peers
-
$11.85 -26.72%
-
$28.65 -23.34%
-
$38.39 -21.12%
Dan Fitzpatrick
Stock Market Mentor gives you EVERYTHING you need to succeed in the market; all in one place. How easy is that? Dan Fitzpatrick and his elite community of traders share trading ideas, strategies and much more. Dan Fitzpatrick--a world class Technical Analyst, trading coach and regular CNBC contributor--gives you access to all of this with a 30 day trial membership for just $7.77. Get started TODAY and start trading better TOMORROW with the following premium content:
- Nightly video Strategy Sessions with a game plan for tomorrow
- Got a stock you want Dan to look at? Just ask.
- Patent pending video alerts instantly delivered to you when one of Dan’s trading signals is triggered. This is not your typical price alert. This is a short video explaining the action you need to take to make money. No more “Woulda, coulda, shoulda”
- Access to over 90,400 stock analysis videos
- Access an ever expanding library (90,400) of educational videos that will save you time and make you money
Join a team of friends and traders that have one thing in common; a burning desire to succeed.
Become a Member Today!
Gain immediate access to all our exclusive articles, features, how-to's, discussion group and much more...
Satisfaction Guaranteed!
Your Stock Market Mentor membership comes with a 30 day, no questions asked, 100% money back guarantee!